Report Tools

F. Hoffmann-La Roche Ltd - SWOT, Strategy and Corporate Finance Report

Published: July 2013 · Publisher: MarketLine
F. Hoffmann-La Roche Ltd - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc.
Report Type Company Profiles
Language English
Format Electronic (PDF)
Pages69
Frequency Updated Annually
Availability Will be emailed within 1 business day
Reference No. 0109-6499
Price € 129,00
Options
  • Description
  • Table of Contents
  • Ask a Question
F. Hoffmann-La Roche Ltd - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360˚ view of the company.

Features:

- Detailed information on F. Hoffmann-La Roche Ltd required for business and competitor intelligence needs
- A study of the major internal and external factors affecting F. Hoffmann-La Roche Ltd in the form of a SWOT analysis
- An in-depth view of the business model of F. Hoffmann-La Roche Ltd including a breakdown and examination of key business segments
- Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for F. Hoffmann-La Roche Ltd
- Intelligence on F. Hoffmann-La Roche Ltdnv’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about F. Hoffmann-La Roche Ltd, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Highlights:

F. Hoffmann-La Roche Ltd (Roche or 'the group') is one of the leading research-focused healthcare groups in the world. It is engaged in the discovery, development and commercialization of innovative diagnostic and therapeutic products. Roche is headquartered in Basel, Switzerland, and employed 82,089 people as of December 31, 2012. The group recorded revenues of CHF45,499 million ($48,533.8 million*) during the financial year ended December 2012 (FY2012), an increase of 7% over FY2011. The operating profit of the group was CHF14,125 million ($15,067.1 million*) in FY2012, an increase of 5% over FY2011. The net profit was CHF9,539 million ($10,175.3 million*) in FY2012, an increase of 2.1% over FY2011. *Calculated using the constant conversion rate of CHF1 = $1.0667 for the year ended December 31, 2012.

Reasons to Purchase:

- Gain understanding of F. Hoffmann-La Roche Ltd and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess F. Hoffmann-La Roche Ltd as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers' businesses better
- Stay up to date on F. Hoffmann-La Roche Ltd’s business structure, strategy and prospects

Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.
Company Snapshot
F. Hoffmann-La Roche Ltd: Company Overview
F. Hoffmann-La Roche Ltd: Overview and Key Facts
F. Hoffmann-La Roche Ltd: Overview
F. Hoffmann-La Roche Ltd: Key Facts
F. Hoffmann-La Roche Ltd: Key Employees
F. Hoffmann-La Roche Ltd: Key Employee Biographies
F. Hoffmann-La Roche Ltd: Major Products and Services
F. Hoffmann-La Roche Ltd: Company History
F. Hoffmann-La Roche Ltd: Management Statement
F. Hoffmann-La Roche Ltd: Locations and Subsidiaries
F. Hoffmann-La Roche Ltd: Key Competitors
F. Hoffmann-La Roche Ltd: Company Analysis
F. Hoffmann-La Roche Ltd: Business Description
F. Hoffmann-La Roche Ltd: SWOT Analysis
F. Hoffmann-La Roche Ltd: SWOT Overview
F. Hoffmann-La Roche Ltd: Strengths
F. Hoffmann-La Roche Ltd: Weaknesses
F. Hoffmann-La Roche Ltd: Opportunities
F. Hoffmann-La Roche Ltd: Threats
F. Hoffmann-La Roche Ltd: Financial Analysis
F. Hoffmann-La Roche Ltd: Financial Overview
F. Hoffmann-La Roche Ltd: Five Year Company Financials
F. Hoffmann-La Roche Ltd: Key Income Statement Data
F. Hoffmann-La Roche Ltd: Key Balance Sheet Data
F. Hoffmann-La Roche Ltd: Key Cash Flow Data
F. Hoffmann-La Roche Ltd: Key Market Data
F. Hoffmann-La Roche Ltd: Valuation Ratios
F. Hoffmann-La Roche Ltd: Profitability Ratios
F. Hoffmann-La Roche Ltd: Management Efficiency Ratios
F. Hoffmann-La Roche Ltd: Financial Strength Ratios
F. Hoffmann-La Roche Ltd: Operational Efficiency Ratios
F. Hoffmann-La Roche Ltd: Others
F. Hoffmann-La Roche Ltd: Corporate Financial Deals Activity
F. Hoffmann-La Roche Ltd: Financial Deals Overview
F. Hoffmann-La Roche Ltd: Targets and Partners
F. Hoffmann-La Roche Ltd: Top Deals 2009 - 2013YTD*
F. Hoffmann-La Roche Ltd: Corporate Venturing
F. Hoffmann-La Roche Ltd: Partnership
F. Hoffmann-La Roche Ltd: Divestments
F. Hoffmann-La Roche Ltd: Recent Developments
F. Hoffmann-La Roche Ltd: News and Events Summary
F. Hoffmann-La Roche Ltd: Business Expansion
F. Hoffmann-La Roche Ltd: Contracts
F. Hoffmann-La Roche Ltd: Financial Deals
F. Hoffmann-La Roche Ltd: Regulatory and Legal Events
F. Hoffmann-La Roche Ltd: Research & Development
Appendix
Contact Us
Methodology
Definitions


List of Tables

Table 1: F. Hoffmann-La Roche Ltd: Key Facts
Table 2: F. Hoffmann-La Roche Ltd: Key Employees
Table 4: F. Hoffmann-La Roche Ltd: Key Competitors
Table 5: F. Hoffmann-La Roche Ltd: Key Income Statement Data
Table 6: F. Hoffmann-La Roche Ltd: Key Balance Sheet Data
Table 7: F. Hoffmann-La Roche Ltd: Key Cash Flow Data
Table 8: F. Hoffmann-La Roche Ltd: Key Market Data
Table 9: F. Hoffmann-La Roche Ltd: Key Growth Ratios
Table 10: F. Hoffmann-La Roche Ltd: Valuation Ratios
Table 11: F. Hoffmann-La Roche Ltd: Profitability Ratios
Table 12: F. Hoffmann-La Roche Ltd: Management Efficiency Ratios
Table 13: F. Hoffmann-La Roche Ltd: Financial Strength Ratios
Table 14: F. Hoffmann-La Roche Ltd: Operational Efficiency Ratios
Table 15: F. Hoffmann-La Roche Ltd: Others
Table 16: F. Hoffmann-La Roche Ltd: Deal Activity by Deal Type - Volume (TTM*)
Table 17: F. Hoffmann-La Roche Ltd: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Table 18: F. Hoffmann-La Roche Ltd: Targets and Partners
Table 19: F. Hoffmann-La Roche Ltd: Top Deals 2009 - 2013YTD*
Table 20: F. Hoffmann-La Roche Ltd: Corporate Venturing Volume and Value Trend (2009 - YTD*2013)
Table 21: F. Hoffmann-La Roche Ltd: Corporate Venturing by Geography (2009 - YTD*2013)
Table 22: F. Hoffmann-La Roche Ltd: Partnership Volume and Value Trend (2009 - YTD*2013)
Table 23: F. Hoffmann-La Roche Ltd: Partnership Trend by Deal Type (2009 - YTD*2013)
Table 24: F. Hoffmann-La Roche Ltd: Divestments Volume and Value Trend (2009 - YTD*2013)
Table 25: F. Hoffmann-La Roche Ltd: Divestments by Geography (2009 - YTD*2013)
Table 26: F. Hoffmann-La Roche Ltd: News and Events Summary
Table 27: F. Hoffmann-La Roche Ltd: Business Expansion
Table 28: F. Hoffmann-La Roche Ltd: Contracts
Table 29: F. Hoffmann-La Roche Ltd: Financial Deals
Table 30: F. Hoffmann-La Roche Ltd: Regulatory and Legal Events
Table 31: F. Hoffmann-La Roche Ltd: Research & Development

List of Figures

Figure 1: F. Hoffmann-La Roche Ltd: Revenue to Net Income (2007-2011)
Figure 2: F. Hoffmann-La Roche Ltd: Revenue/Employee to Net Income/Employee (2007-2011)
Figure 3: F. Hoffmann-La Roche Ltd: Current Assets to Current Liabilities (2007-2011)
Figure 4: F. Hoffmann-La Roche Ltd: Assets, Liabilities to Total Equity (2007-2011)
Figure 5: F. Hoffmann-La Roche Ltd: Free Cash Flow to Cash from Operating Activities (2007-2011)
Figure 6: F. Hoffmann-La Roche Ltd: Net Change in Cash (2007-2011)
Figure 7: F. Hoffmann-La Roche Ltd: Market Capitalization to Year-end Share Price (2007-2011)
Figure 8: F. Hoffmann-La Roche Ltd: Enterprise Value (2007-2011)
Figure 9: F. Hoffmann-La Roche Ltd: Deal Activity by Deal Type - Volume (TTM*)
Figure 10: F. Hoffmann-La Roche Ltd: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Figure 11: F. Hoffmann-La Roche Ltd: Corporate Venturing Volume and Value Trend (2009 - YTD*2013)
Figure 12: F. Hoffmann-La Roche Ltd: Corporate Venturing by Geography (2009 - YTD*2013)
Figure 13: F. Hoffmann-La Roche Ltd: Partnership Volume and Value Trend (2009 - YTD*2013)
Figure 14: F. Hoffmann-La Roche Ltd: Partnership Trend by Deal Type (2009 - YTD*2013)
Figure 15: F. Hoffmann-La Roche Ltd: Divestments Volume and Value Trend (2009 - YTD*2013)
Figure 16: F. Hoffmann-La Roche Ltd: Divestments by Geography (2009 - YTD*2013)
Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.